Product Overview
Maharishi Ayurveda Amlant Tablet is a traditional Ayurvedic formulation commonly included in wellness routines to support digestive wellness, healthy acid balance, gut health, and overall well-being. It is suitable for individuals with concerns such as hyperacidity, heartburn, acid reflux, indigestion, bloating, nausea, abdominal discomfort, constipation, and daily digestive wellness goals, as part of a healthy lifestyle.
Ingredients:
Shunthi (Zingiber officinale) 3.19 mg, Kali Mirch (Piper nigrum) 3.19 mg, Pippali (Piper longum) 3.19 mg, Haritaki (Terminalia chebula) 3.19 mg, Vibhitaki (Terminalia bellirica) 3.19 mg, Nagar Motha (Cyperus scariosus) 3.19 mg, Tejpatra (Cinnamomum tamala) 3.19 mg, Vai Vidang (Embelia ribes) 3.19 mg, etc.
Benefits:
- Supports healthy acid balance and digestive wellness
- Helps maintain stomach comfort and digestive function
- Supports gut health and digestive system wellness
- Promotes relief from bloating, abdominal discomfort, and occasional constipation
- Supports overall digestive wellness and daily well-being
How to Use:
- Take 1–2 tablets twice daily after meals, or as directed by an Ayurvedic healthcare professional.
Safety Information:
- Do not exceed the recommended dosage
- Store in a cool, dry place away from direct sunlight
- Keep out of reach of children
FAQs
Q1. What is Maharishi Ayurveda Amlant Tablet used for?
Maharishi Ayurveda Amlant Tablet is commonly used to support digestive wellness, healthy acid balance, gut health, and overall well-being naturally.
Q2. Can Maharishi Ayurveda Amlant Tablet support acidity and heartburn?
Yes, it is traditionally included in wellness routines to support healthy acid balance, stomach comfort, digestive wellness, and relief from heartburn and acidity-related discomfort.
Q3. Does Maharishi Ayurveda Amlant Tablet support gut health?
Its traditional Ayurvedic ingredients are commonly used to support gut health, digestive function, stomach comfort, and overall gastrointestinal wellness.





Reviews
There are no reviews yet.